CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 64 enrolled
Drug / intervention
Vitamin D2 +2 moredrug
Likely dose
Vitamin D2 000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00424619
NCT00424619Phase 4Completed
CompareCT.gov

A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients

McMaster University·interventional·Posted Jan 19, 2007·Updated Jul 16, 2025

In Brief

A Phase 4 clinical trial evaluating Vitamin D2 and Placebo for Hip Fracture. Completed, enrolled 64 participants.

Detailed Summary

The purpose of the study is to determine the best dose of Vitamin D to give to hip fracture patients to achieve the optimal therapeutic level.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHip Fracture
Countries--
CollaboratorsMerck Frosst Canada Ltd.

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 19, 2007
Enrollment StartOct 1, 2007
Primary CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 19.5 years ago

Interventions

Vitamin D2drug

50 000 IU vitamin D2, one time bolus dose

Vitamin D2drug

100 000 IU vitamin D2, one time bolus dose

Placebodrug

Placebo, 1 time bolus dose